feed,title,long_url,short_url
Benzinga,"AstraZeneca's Nirsevimab Shows Favorable Safety, Tolerability Profile In Infants At High Risk Of RSV",https://benzinga.com/general/biotech/21/06/21740101/astrazenecas-nirsevimab-shows-favorable-safety-tolerability-profile-in-infants-at-high-risk-of-rs,https://j.mp/3x1gooo
Benzinga,"Roche's Enspryng Wins European Approval For Spinal Cord, Optic Nerve Inflammation Disorder",https://benzinga.com/general/biotech/21/06/21740100/roches-enspryng-wins-european-approval-for-spinal-cord-optic-nerve-inflammation-disorder,https://j.mp/3qvYkjw
